Evoke Pharma Stock Technical Analysis
EVOK Stock | USD 0.48 0.07 12.73% |
As of the 19th of April, Evoke Pharma shows the Standard Deviation of 5.89, variance of 34.67, and Mean Deviation of 4.22. Evoke Pharma technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down and interpolate data for thirteen technical drivers for Evoke Pharma, which can be compared to its peers. Please confirm Evoke Pharma variance and potential upside to decide if Evoke Pharma is priced favorably, providing market reflects its regular price of 0.48 per share. As Evoke Pharma is a penny stock we also recommend to verify its jensen alpha numbers.
Evoke Pharma Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Evoke, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to EvokeEvoke |
Evoke Pharma Analyst Consensus
Target Price | Advice | # of Analysts | |
7.0 | Buy | 1 | Odds |
Most Evoke analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Evoke stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Evoke Pharma, talking to its executives and customers, or listening to Evoke conference calls.
Evoke Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Evoke Pharma Technical Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Evoke Pharma volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Evoke Pharma Trend Analysis
Use this graph to draw trend lines for Evoke Pharma. You can use it to identify possible trend reversals for Evoke Pharma as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Evoke Pharma price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Evoke Pharma Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Evoke Pharma applied against its price change over selected period. The best fit line has a slop of 0.0029 , which may suggest that Evoke Pharma market price will keep on failing further. It has 122 observation points and a regression sum of squares at 0.32, which is the sum of squared deviations for the predicted Evoke Pharma price change compared to its average price change.About Evoke Pharma Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Evoke Pharma on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Evoke Pharma based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Evoke Pharma price pattern first instead of the macroeconomic environment surrounding Evoke Pharma. By analyzing Evoke Pharma's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Evoke Pharma's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Evoke Pharma specific price patterns or momentum indicators. Please read more on our technical analysis page.
2023 | 2024 (projected) | Dividend Yield | 0.0698 | 0.0621 | Price To Sales Ratio | 0.68 | 0.64 |
Evoke Pharma April 19, 2024 Technical Indicators
Most technical analysis of Evoke help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Evoke from various momentum indicators to cycle indicators. When you analyze Evoke charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Risk Adjusted Performance | (0.07) | |||
Market Risk Adjusted Performance | (2.65) | |||
Mean Deviation | 4.22 | |||
Coefficient Of Variation | (809.36) | |||
Standard Deviation | 5.89 | |||
Variance | 34.67 | |||
Information Ratio | (0.14) | |||
Jensen Alpha | (0.75) | |||
Total Risk Alpha | (1.30) | |||
Treynor Ratio | (2.66) | |||
Maximum Drawdown | 25.19 | |||
Value At Risk | (11.27) | |||
Potential Upside | 9.43 | |||
Skewness | 0.5471 | |||
Kurtosis | 1.69 |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evoke Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Evoke Stock please use our How to buy in Evoke Stock guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Complementary Tools for Evoke Stock analysis
When running Evoke Pharma's price analysis, check to measure Evoke Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evoke Pharma is operating at the current time. Most of Evoke Pharma's value examination focuses on studying past and present price action to predict the probability of Evoke Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evoke Pharma's price. Additionally, you may evaluate how the addition of Evoke Pharma to your portfolios can decrease your overall portfolio volatility.
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |
Is Evoke Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evoke Pharma. If investors know Evoke will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evoke Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.33) | Revenue Per Share 1.55 | Quarterly Revenue Growth 1.105 | Return On Assets (0.49) | Return On Equity (10.35) |
The market value of Evoke Pharma is measured differently than its book value, which is the value of Evoke that is recorded on the company's balance sheet. Investors also form their own opinion of Evoke Pharma's value that differs from its market value or its book value, called intrinsic value, which is Evoke Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evoke Pharma's market value can be influenced by many factors that don't directly affect Evoke Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evoke Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evoke Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evoke Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.